Sensus Healthcare Return on Equity (ROE) Growth & History (SRTS)
Sensus Healthcare's return on equity was −14.85% for fiscal 2025.
View full Sensus Healthcare company overviewSensus Healthcare annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −14.85% | −27.56 pp |
| 2024 | 2024-12-31 | 12.70% | +11.70 pp |
| 2023 | 2023-12-31 | 1.00% | −64.45 pp |
| 2022 | 2022-12-31 | 65.45% | +48.11 pp |
| 2021 | 2021-12-31 | 17.34% | +44.96 pp |
| 2020 | 2020-12-31 | −27.62% | −21.38 pp |
| 2019 | 2019-12-31 | −6.24% | +4.36 pp |
| 2018 | 2018-12-31 | −10.61% | +16.92 pp |
| 2017 | 2017-12-31 | −27.53% | −24.26 pp |
| 2016 | 2016-12-31 | −3.27% | — |
Sensus Healthcare quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −21.23% | −19.26 pp |
| Q1 2026 | 2026-03-31 | −5.61% | −0.88 pp |
| Q4 2025 | 2025-12-31 | −6.38% | −9.19 pp |
| Q3 2025 | 2025-09-30 | −1.83% | −4.10 pp |
| Q2 2025 | 2025-06-30 | −1.97% | −5.07 pp |
| Q1 2025 | 2025-03-31 | −4.73% | −9.27 pp |
| Q4 2024 | 2024-12-31 | 2.81% | −6.20 pp |
| Q3 2024 | 2024-09-30 | 2.27% | +5.47 pp |
| Q2 2024 | 2024-06-30 | 3.10% | +3.92 pp |
| Q1 2024 | 2024-03-31 | 4.55% | +8.56 pp |
| Q4 2023 | 2023-12-31 | 9.01% | +3.07 pp |
| Q3 2023 | 2023-09-30 | −3.20% | −7.17 pp |
| Q2 2023 | 2023-06-30 | −0.82% | −8.88 pp |
| Q1 2023 | 2023-03-31 | −4.01% | −50.93 pp |
| Q4 2022 | 2022-12-31 | 5.94% | −16.87 pp |
| Q3 2022 | 2022-09-30 | 3.97% | +3.01 pp |
| Q2 2022 | 2022-06-30 | 8.05% | +9.43 pp |
| Q1 2022 | 2022-03-31 | 46.91% | +52.23 pp |
| Q4 2021 | 2021-12-31 | 22.81% | +17.96 pp |
| Q3 2021 | 2021-09-30 | 0.96% | +8.92 pp |
| Q2 2021 | 2021-06-30 | −1.37% | +9.67 pp |
| Q1 2021 | 2021-03-31 | −5.32% | +8.33 pp |
| Q4 2020 | 2020-12-31 | 4.85% | +1.06 pp |
| Q3 2020 | 2020-09-30 | −7.97% | −5.27 pp |
| Q2 2020 | 2020-06-30 | −11.04% | −11.45 pp |
| Q1 2020 | 2020-03-31 | −13.65% | −5.74 pp |
| Q4 2019 | 2019-12-31 | 3.79% | +3.40 pp |
| Q3 2019 | 2019-09-30 | −2.70% | −0.21 pp |
| Q2 2019 | 2019-06-30 | 0.41% | +5.36 pp |
| Q1 2019 | 2019-03-31 | −7.91% | +1.94 pp |
| Q4 2018 | 2018-12-31 | 0.39% | +3.84 pp |
| Q3 2018 | 2018-09-30 | −2.49% | +5.29 pp |
| Q2 2018 | 2018-06-30 | −4.95% | +0.82 pp |
| Q1 2018 | 2018-03-31 | −9.85% | +1.02 pp |
| Q4 2017 | 2017-12-31 | −3.45% | −3.67 pp |
| Q3 2017 | 2017-09-30 | −7.78% | −7.57 pp |
| Q2 2017 | 2017-06-30 | −5.77% | −2.40 pp |
| Q1 2017 | 2017-03-31 | −10.87% | — |
| Q4 2016 | 2016-12-31 | 0.22% | — |
| Q3 2016 | 2016-09-30 | −0.20% | — |
| Q2 2016 | 2016-06-30 | −3.37% | — |
Sensus Healthcare return on equity trends
Over the last five fiscal years, Sensus Healthcare's return on equity increased from −27.62% to −14.85%, a change of +12.77 percentage points. The latest reported quarter, Q2 2026, shows −21.23%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sensus Healthcare source filings ↗